BIIB
insider transactionsBIOGEN INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-6.1K
3 buy · 6.1K sell
Net value · 365d
-$1.0M
$585 in · $1.0M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
5
3 buy · 6.1K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Head of Corporate Development
$0
939 sh
Own New
-
Other·F
Head of Corporate Development
$85.1K
455 sh · $187.06
Own -7%
-
Exercise·M
Head of Corporate Development
$0
939 sh
Own +16%
-
Exercise·M
Chief Accounting Officer
$0
181 sh
Own +99%
-
Other·F
Chief Accounting Officer
$9.9K
54 sh · $183.78
Own -4%
-
Exercise·M
Chief Accounting Officer
$0
181 sh
Own +15%
-
Grant·A
Kramer Robin KEY
Chief Financial Officer
$0
8.4K sh
Own New
-
Grant·A
President and CEO
$0
38.0K sh
Own New
-
Grant·A
Head of Global Product Strat.
$0
7.4K sh
Own New
-
Grant·A
Head of Corporate Development
$0
8.0K sh
Own New
-
Grant·A
Head of Development
$0
10.6K sh
Own New
-
Grant·A
EVP Chief Legal Officer
$0
8.4K sh
Own New
-
Grant·A
Head of Pharm Ops and Tech
$0
10.6K sh
Own New
-
Grant·A
Head of Research
$0
8.4K sh
Own New
-
Grant·A
EVP, Human Resources
$0
8.0K sh
Own New
-
Grant·A
Chief Accounting Officer
$0
1.8K sh
Own New
-
Buy·P
Head of Pharm Ops and Tech
$585
3 sh · $195.04
Own +0%
-
Sell·S
Head of Development · 10b5-1
$531.5K
2.7K sh · $199.83
Own -25%
-
Exercise·M
President and CEO
$0
15.5K sh
Own +100%
-
Exercise·M
President and CEO
$0
9.0K sh
Own +900800%
-
Other·F
President and CEO
$876.3K
4.4K sh · $201.18
Own -17%
-
Exercise·M
President and CEO
$0
15.5K sh
Own +73%
-
Other·F
President and CEO
$1.3M
6.6K sh · $201.18
Own -18%
-
Exercise·M
President and CEO
$0
9.0K sh
Own +55%
-
Exercise·M
Head of Pharm Ops and Tech
$0
4.7K sh
Own +100%
-
Exercise·M
Head of Pharm Ops and Tech
$0
1.9K sh
Own New
-
Exercise·M
Head of Pharm Ops and Tech
$0
2.1K sh
Own New
-
Exercise·M
Head of Pharm Ops and Tech
$0
4.7K sh
Own +29%
-
Exercise·M
Head of Pharm Ops and Tech
$0
2.1K sh
Own +15%
-
Other·F
Head of Pharm Ops and Tech
$204.6K
1.0K sh · $201.18
Own -6%
-
Exercise·M
Head of Pharm Ops and Tech
$0
1.9K sh
Own +13%
-
Other·F
Head of Pharm Ops and Tech
$183.9K
914 sh · $201.18
Own -5%
-
Other·F
Head of Pharm Ops and Tech
$283.3K
1.4K sh · $201.18
Own -7%
-
Exercise·M
Head of Research
$0
1.4K sh
Own New
-
Exercise·M
Head of Research
$0
1.9K sh
Own +100%
-
Exercise·M
Head of Research
$0
1.4K sh
Own +77%
-
Other·F
Head of Research
$81.9K
407 sh · $201.18
Own -13%
-
Exercise·M
Head of Research
$0
1.9K sh
Own +68%
-
Other·F
Head of Research
$117.5K
584 sh · $201.18
Own -13%
-
Exercise·M
EVP Chief Legal Officer
$0
2.2K sh
Own New
-
Exercise·M
EVP Chief Legal Officer
$0
1.9K sh
Own New
-
Exercise·M
EVP Chief Legal Officer
$0
4.9K sh
Own +100%
-
Exercise·M
EVP Chief Legal Officer
$0
2.2K sh
Own +6%
-
Other·F
EVP Chief Legal Officer
$213.0K
1.1K sh · $201.18
Own -3%
-
Exercise·M
EVP Chief Legal Officer
$0
1.9K sh
Own +5%
-
Other·F
EVP Chief Legal Officer
$187.3K
931 sh · $201.18
Own -2%
-
Other·F
EVP Chief Legal Officer
$304.6K
1.5K sh · $201.18
Own -3%
-
Exercise·M
EVP Chief Legal Officer
$0
4.9K sh
Own +13%
-
Exercise·M
Head of Corporate Development
$0
3.3K sh
Own +100%
-
Exercise·M
Head of Corporate Development
$0
1.8K sh
Own New
-
Other·F
Head of Corporate Development
$118.5K
589 sh · $201.18
Own -14%
-
Exercise·M
Head of Corporate Development
$0
1.8K sh
Own +76%
-
Exercise·M
Head of Corporate Development
$0
3.3K sh
Own +91%
-
Other·F
Head of Corporate Development
$200.0K
994 sh · $201.18
Own -14%
-
Exercise·M
Kramer Robin KEY
Chief Financial Officer
$0
3.5K sh
Own +100%
-
Exercise·M
Kramer Robin KEY
Chief Financial Officer
$0
703 sh
Own +70300%
-
Exercise·M
Kramer Robin KEY
Chief Financial Officer
$0
789 sh
Own New
-
Other·F
Kramer Robin KEY
Chief Financial Officer
$41.6K
207 sh · $201.18
Own -2%
-
Exercise·M
Kramer Robin KEY
Chief Financial Officer
$0
789 sh
Own +10%
-
Other·F
Kramer Robin KEY
Chief Financial Officer
$54.9K
273 sh · $201.18
Own -3%
-
Other·F
Kramer Robin KEY
Chief Financial Officer
$213.9K
1.1K sh · $201.18
Own -8%
-
Exercise·M
Kramer Robin KEY
Chief Financial Officer
$0
3.5K sh
Own +39%
-
Exercise·M
Kramer Robin KEY
Chief Financial Officer
$0
703 sh
Own +8%
-
Exercise·M
Head of Development · 10b5-1
$0
2.2K sh
Own New
-
Exercise·M
Head of Development · 10b5-1
$0
4.7K sh
Own +100%
-
Other·F
Head of Development · 10b5-1
$212.4K
1.1K sh · $201.18
Own -12%
-
Exercise·M
Head of Development · 10b5-1
$0
4.7K sh
Own +63%
-
Other·F
Head of Development · 10b5-1
$284.1K
1.4K sh · $201.18
Own -12%
-
Exercise·M
Head of Development · 10b5-1
$0
2.2K sh
Own +35%
-
Exercise·M
EVP, Human Resources
$0
1.6K sh
Own New
-
Exercise·M
EVP, Human Resources
$0
1.8K sh
Own New
-
Exercise·M
EVP, Human Resources
$0
3.7K sh
Own +100%
-
Other·F
EVP, Human Resources
$227.7K
1.1K sh · $201.18
Own -5%
-
Other·F
EVP, Human Resources
$134.0K
666 sh · $201.18
Own -3%
-
Exercise·M
EVP, Human Resources
$0
1.8K sh
Own +10%
-
Other·F
EVP, Human Resources
$159.1K
791 sh · $201.18
Own -4%
-
Exercise·M
EVP, Human Resources
$0
1.6K sh
Own +9%
-
Exercise·M
EVP, Human Resources
$0
3.7K sh
Own +19%
-
Exercise·M
Head of Global Product Strat.
$0
2.0K sh
Own New
-
Exercise·M
Head of Global Product Strat.
$0
3.0K sh
Own +100%
-
Exercise·M
Head of Global Product Strat.
$0
1.8K sh
Own New
-
Exercise·M
Head of Global Product Strat.
$0
3.0K sh
Own +35%
-
Other·F
Head of Global Product Strat.
$155.9K
775 sh · $201.18
Own -7%
-
Other·F
Head of Global Product Strat.
$92.1K
458 sh · $201.18
Own -5%
-
Exercise·M
Head of Global Product Strat.
$0
1.8K sh
Own +24%
-
Other·F
Head of Global Product Strat.
$161.9K
805 sh · $201.18
Own -10%
-
Exercise·M
Head of Global Product Strat.
$0
2.0K sh
Own +33%
-
Exercise·M
Chief Accounting Officer
$0
257 sh
Own New
-
Exercise·M
Chief Accounting Officer
$0
305 sh
Own New
-
Exercise·M
Chief Accounting Officer
$0
517 sh
Own +100%
-
Exercise·M
Chief Accounting Officer
$0
305 sh
Own +45%
-
Other·F
Chief Accounting Officer
$36.2K
180 sh · $201.18
Own -13%
-
Exercise·M
Chief Accounting Officer
$0
257 sh
Own +52%
-
Other·F
Chief Accounting Officer
$15.3K
76 sh · $201.18
Own -10%
-
Other·F
Chief Accounting Officer
$20.7K
103 sh · $201.18
Own -11%
-
Exercise·M
Chief Accounting Officer
$0
517 sh
Own +59%
-
Sell·S
Head of Development · 10b5-1
$134.1K
748 sh · $179.30
Own -11%
-
Exercise·M
Head of Development · 10b5-1
$0
1.8K sh
Own New
-
Exercise·M
Head of Development · 10b5-1
$0
1.8K sh
Own +32%
-
Other·F
Head of Development · 10b5-1
$104.7K
582 sh · $179.89
Own -8%
-
Exercise·M
President and CEO
$0
7.0K sh
Own New
-
Other·F
President and CEO
$605.2K
3.4K sh · $177.78
Own -17%
-
Exercise·M
President and CEO
$0
7.0K sh
Own +55%
-
Exercise·M
Head of Research
$0
695 sh
Own New
-
Other·F
Head of Research
$52.0K
337 sh · $154.27
Own -16%
-
Exercise·M
Head of Research
$0
695 sh
Own +48%
-
Exercise·M
Chief Accounting Officer
$0
26 sh
Own +2600%
-
Other·F
Chief Accounting Officer
$1.2K
8 sh · $155.25
Own -2%
-
Exercise·M
Chief Accounting Officer
$0
26 sh
Own +5%
-
Sell·S
Head of Development · 10b5-1
$69.0K
517 sh · $133.55
Own -8%
-
Exercise·M
Head of Development · 10b5-1
$0
1.7K sh
Own New
-
Exercise·M
Head of Development · 10b5-1
$0
1.7K sh
Own +31%
-
Other·F
Head of Development · 10b5-1
$106.7K
807 sh · $132.22
Own -11%
-
Sell·S
Head of Global Product Strat. · 10b5-1
$300.1K
2.2K sh · $135.00
Own -26%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 1, 2026 | Keeney Adam | Exercise M | 939 | $0 |
| May 1, 2026 | Keeney Adam | Other F | 455 | $85.1K |
| May 1, 2026 | Keeney Adam | Exercise M | 939 | $0 |
| Apr 1, 2026 | Godbout Sean | Exercise M | 181 | $0 |
| Apr 1, 2026 | Godbout Sean | Other F | 54 | $9.9K |
| Apr 1, 2026 | Godbout Sean | Exercise M | 181 | $0 |
| Feb 13, 2026 | Kramer Robin KEY | Grant A | 8.4K | $0 |
| Feb 13, 2026 | Viehbacher Christopher KEY | Grant A | 38.0K | $0 |
| Feb 13, 2026 | Izzar Rachid | Grant A | 7.4K | $0 |
| Feb 13, 2026 | Keeney Adam | Grant A | 8.0K | $0 |
| Feb 13, 2026 | Singhal Priya | Grant A | 10.6K | $0 |
| Feb 13, 2026 | ALEXANDER SUSAN H | Grant A | 8.4K | $0 |
| Feb 13, 2026 | Murphy Nicole | Grant A | 10.6K | $0 |
| Feb 13, 2026 | Grogan Jane | Grant A | 8.4K | $0 |
| Feb 13, 2026 | Gregory Ginger | Grant A | 8.0K | $0 |
| Feb 13, 2026 | Godbout Sean | Grant A | 1.8K | $0 |
| Feb 12, 2026 | Murphy Nicole | Buy P | 3 | $585 |
| Feb 9, 2026 | Singhal Priya 10b5-1 | Sell S | 2.7K | $531.5K |
| Feb 6, 2026 | Viehbacher Christopher KEY | Exercise M | 15.5K | $0 |
| Feb 6, 2026 | Viehbacher Christopher KEY | Exercise M | 9.0K | $0 |
| Feb 6, 2026 | Viehbacher Christopher KEY | Other F | 4.4K | $876.3K |
| Feb 6, 2026 | Viehbacher Christopher KEY | Exercise M | 15.5K | $0 |
| Feb 6, 2026 | Viehbacher Christopher KEY | Other F | 6.6K | $1.3M |
| Feb 6, 2026 | Viehbacher Christopher KEY | Exercise M | 9.0K | $0 |
| Feb 6, 2026 | Murphy Nicole | Exercise M | 4.7K | $0 |
| Feb 6, 2026 | Murphy Nicole | Exercise M | 1.9K | $0 |
| Feb 6, 2026 | Murphy Nicole | Exercise M | 2.1K | $0 |
| Feb 6, 2026 | Murphy Nicole | Exercise M | 4.7K | $0 |
| Feb 6, 2026 | Murphy Nicole | Exercise M | 2.1K | $0 |
| Feb 6, 2026 | Murphy Nicole | Other F | 1.0K | $204.6K |
| Feb 6, 2026 | Murphy Nicole | Exercise M | 1.9K | $0 |
| Feb 6, 2026 | Murphy Nicole | Other F | 914 | $183.9K |
| Feb 6, 2026 | Murphy Nicole | Other F | 1.4K | $283.3K |
| Feb 6, 2026 | Grogan Jane | Exercise M | 1.4K | $0 |
| Feb 6, 2026 | Grogan Jane | Exercise M | 1.9K | $0 |
| Feb 6, 2026 | Grogan Jane | Exercise M | 1.4K | $0 |
| Feb 6, 2026 | Grogan Jane | Other F | 407 | $81.9K |
| Feb 6, 2026 | Grogan Jane | Exercise M | 1.9K | $0 |
| Feb 6, 2026 | Grogan Jane | Other F | 584 | $117.5K |
| Feb 6, 2026 | ALEXANDER SUSAN H | Exercise M | 2.2K | $0 |
| Feb 6, 2026 | ALEXANDER SUSAN H | Exercise M | 1.9K | $0 |
| Feb 6, 2026 | ALEXANDER SUSAN H | Exercise M | 4.9K | $0 |
| Feb 6, 2026 | ALEXANDER SUSAN H | Exercise M | 2.2K | $0 |
| Feb 6, 2026 | ALEXANDER SUSAN H | Other F | 1.1K | $213.0K |
| Feb 6, 2026 | ALEXANDER SUSAN H | Exercise M | 1.9K | $0 |
| Feb 6, 2026 | ALEXANDER SUSAN H | Other F | 931 | $187.3K |
| Feb 6, 2026 | ALEXANDER SUSAN H | Other F | 1.5K | $304.6K |
| Feb 6, 2026 | ALEXANDER SUSAN H | Exercise M | 4.9K | $0 |
| Feb 6, 2026 | Keeney Adam | Exercise M | 3.3K | $0 |
| Feb 6, 2026 | Keeney Adam | Exercise M | 1.8K | $0 |
| Feb 6, 2026 | Keeney Adam | Other F | 589 | $118.5K |
| Feb 6, 2026 | Keeney Adam | Exercise M | 1.8K | $0 |
| Feb 6, 2026 | Keeney Adam | Exercise M | 3.3K | $0 |
| Feb 6, 2026 | Keeney Adam | Other F | 994 | $200.0K |
| Feb 6, 2026 | Kramer Robin KEY | Exercise M | 3.5K | $0 |
| Feb 6, 2026 | Kramer Robin KEY | Exercise M | 703 | $0 |
| Feb 6, 2026 | Kramer Robin KEY | Exercise M | 789 | $0 |
| Feb 6, 2026 | Kramer Robin KEY | Other F | 207 | $41.6K |
| Feb 6, 2026 | Kramer Robin KEY | Exercise M | 789 | $0 |
| Feb 6, 2026 | Kramer Robin KEY | Other F | 273 | $54.9K |
| Feb 6, 2026 | Kramer Robin KEY | Other F | 1.1K | $213.9K |
| Feb 6, 2026 | Kramer Robin KEY | Exercise M | 3.5K | $0 |
| Feb 6, 2026 | Kramer Robin KEY | Exercise M | 703 | $0 |
| Feb 6, 2026 | Singhal Priya 10b5-1 | Exercise M | 2.2K | $0 |
| Feb 6, 2026 | Singhal Priya 10b5-1 | Exercise M | 4.7K | $0 |
| Feb 6, 2026 | Singhal Priya 10b5-1 | Other F | 1.1K | $212.4K |
| Feb 6, 2026 | Singhal Priya 10b5-1 | Exercise M | 4.7K | $0 |
| Feb 6, 2026 | Singhal Priya 10b5-1 | Other F | 1.4K | $284.1K |
| Feb 6, 2026 | Singhal Priya 10b5-1 | Exercise M | 2.2K | $0 |
| Feb 6, 2026 | Gregory Ginger | Exercise M | 1.6K | $0 |
| Feb 6, 2026 | Gregory Ginger | Exercise M | 1.8K | $0 |
| Feb 6, 2026 | Gregory Ginger | Exercise M | 3.7K | $0 |
| Feb 6, 2026 | Gregory Ginger | Other F | 1.1K | $227.7K |
| Feb 6, 2026 | Gregory Ginger | Other F | 666 | $134.0K |
| Feb 6, 2026 | Gregory Ginger | Exercise M | 1.8K | $0 |
| Feb 6, 2026 | Gregory Ginger | Other F | 791 | $159.1K |
| Feb 6, 2026 | Gregory Ginger | Exercise M | 1.6K | $0 |
| Feb 6, 2026 | Gregory Ginger | Exercise M | 3.7K | $0 |
| Feb 6, 2026 | Izzar Rachid | Exercise M | 2.0K | $0 |
| Feb 6, 2026 | Izzar Rachid | Exercise M | 3.0K | $0 |
| Feb 6, 2026 | Izzar Rachid | Exercise M | 1.8K | $0 |
| Feb 6, 2026 | Izzar Rachid | Exercise M | 3.0K | $0 |
| Feb 6, 2026 | Izzar Rachid | Other F | 775 | $155.9K |
| Feb 6, 2026 | Izzar Rachid | Other F | 458 | $92.1K |
| Feb 6, 2026 | Izzar Rachid | Exercise M | 1.8K | $0 |
| Feb 6, 2026 | Izzar Rachid | Other F | 805 | $161.9K |
| Feb 6, 2026 | Izzar Rachid | Exercise M | 2.0K | $0 |
| Feb 6, 2026 | Godbout Sean | Exercise M | 257 | $0 |
| Feb 6, 2026 | Godbout Sean | Exercise M | 305 | $0 |
| Feb 6, 2026 | Godbout Sean | Exercise M | 517 | $0 |
| Feb 6, 2026 | Godbout Sean | Exercise M | 305 | $0 |
| Feb 6, 2026 | Godbout Sean | Other F | 180 | $36.2K |
| Feb 6, 2026 | Godbout Sean | Exercise M | 257 | $0 |
| Feb 6, 2026 | Godbout Sean | Other F | 76 | $15.3K |
| Feb 6, 2026 | Godbout Sean | Other F | 103 | $20.7K |
| Feb 6, 2026 | Godbout Sean | Exercise M | 517 | $0 |
| Feb 2, 2026 | Singhal Priya 10b5-1 | Sell S | 748 | $134.1K |
| Jan 30, 2026 | Singhal Priya 10b5-1 | Exercise M | 1.8K | $0 |
| Jan 30, 2026 | Singhal Priya 10b5-1 | Exercise M | 1.8K | $0 |
| Jan 30, 2026 | Singhal Priya 10b5-1 | Other F | 582 | $104.7K |
| Dec 1, 2025 | Viehbacher Christopher KEY | Exercise M | 7.0K | $0 |
| Dec 1, 2025 | Viehbacher Christopher KEY | Other F | 3.4K | $605.2K |
| Dec 1, 2025 | Viehbacher Christopher KEY | Exercise M | 7.0K | $0 |
| Oct 31, 2025 | Grogan Jane | Exercise M | 695 | $0 |
| Oct 31, 2025 | Grogan Jane | Other F | 337 | $52.0K |
| Oct 31, 2025 | Grogan Jane | Exercise M | 695 | $0 |
| Oct 2, 2025 | Godbout Sean | Exercise M | 26 | $0 |
| Oct 2, 2025 | Godbout Sean | Other F | 8 | $1.2K |
| Oct 2, 2025 | Godbout Sean | Exercise M | 26 | $0 |
| Sep 2, 2025 | Singhal Priya 10b5-1 | Sell S | 517 | $69.0K |
| Aug 29, 2025 | Singhal Priya 10b5-1 | Exercise M | 1.7K | $0 |
| Aug 29, 2025 | Singhal Priya 10b5-1 | Exercise M | 1.7K | $0 |
| Aug 29, 2025 | Singhal Priya 10b5-1 | Other F | 807 | $106.7K |
| Jul 8, 2025 | Izzar Rachid 10b5-1 | Sell S | 2.2K | $300.1K |
About BIIB insider trading
This page tracks insider transactions for BIOGEN INC. (BIIB) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.